Effect of the 5-HT1A partial agonist buspirone on regional brain electrical activity in man:: a functional neuroimaging study using low-resolution electromagnetic tomography (LORETA)

被引:54
作者
Anderer, P
Saletu, B
Pascual-Marqui, RD
机构
[1] Univ Vienna, Dept Psychiat, Div Sleep Res & Pharmacopsychiat, A-1090 Vienna, Austria
[2] Univ Hosp Psychiat, KEY Inst Brain Mind Res, Dept Psychiat, Zurich, Switzerland
关键词
quantitative electroencephalography; pharmaco-EEG; psychopharmacology;
D O I
10.1016/S0925-4927(00)00066-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In a double-blind, placebo-controlled study, the effects of 20 mg buspirone - a 5-HT1A partial agonist - on regional electrical generators within the human brain were investigated utilizing three-dimensional EEG tomography. Nineteen-channel vigilance-controlled EEG recordings were carried out in 20 healthy subjects before and 1, 2, 4, 6 and 8 h after drug intake. Low-resolution electromagnetic tomography (LORETA; Key Institute for Brain-Mind Research, software: http://www.keyinst.unizh.ch) was computed from spectrally analyzed EEG data, and differences between drug- and placebo-induced changes were displayed as statistical parametric maps. Data were registered to the Talairach-Tournoux human brain atlas available as a digitized MRI (McConnell Brain Imaging Centre: http://www.bic.mni.mcgill.ca). At the pharmacodynamic peak (Ist hour), buspirone increased theta and decreased fast alpha and beta sources. Areas of theta increase were mainly the left temporo-occipito-parietal and left prefrontal cortices, which is consistent with PET studies on buspirone-induced decreases in regional cerebral blood flow and fenfluramine-induced serotonin activation demonstrated by changes in regional cerebral glucose metabolism. In later hours (8th hour) with lower buspirone plasma levels, delta, theta, slow alpha and fast beta decreased, predominantly in the prefrontal and anterior limbic lobe. Whereas the results of the Ist hour speak for a slight CNS sedation (more in the sense of relaxation), those obtained in the 8th hour indicate activation. Thus, LORETA may provide useful and direct information on drug-induced changes in central nervous system function in man. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:81 / 96
页数:16
相关论文
共 84 条
  • [1] Differential effects of normal aging on sources of standard N1, target N1 and target P300 auditory event-related brain potentials revealed by low resolution electromagnetic tomography (LORETA)
    Anderer, P
    Pascual-Marqui, RD
    Semlitsch, HV
    Saletu, B
    [J]. EVOKED POTENTIALS-ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1998, 108 (02): : 160 - 174
  • [2] Electrical sources of P300 event-related brain potentials revealed by low resolution electromagnetic tomography .1. Effects of normal aging
    Anderer, P
    Pascual-Marqui, RD
    Semlitsch, HV
    Saletu, B
    [J]. NEUROPSYCHOBIOLOGY, 1998, 37 (01) : 20 - 27
  • [3] ARTIFACT PROCESSING IN TOPOGRAPHIC MAPPING OF ELECTROENCEPHALOGRAPHIC ACTIVITY IN NEUROPSYCHOPHARMACOLOGY
    ANDERER, P
    SEMLITSCH, HV
    SALETU, B
    BARBANOJ, MJ
    [J]. PSYCHIATRY RESEARCH-NEUROIMAGING, 1992, 45 (02) : 79 - 93
  • [4] ANDERER P, 1987, METHOD FIND EXP CLIN, V9, P371
  • [5] Electrical sources of P300 event-related brain potentials revealed by low resolution electromagnetic tomography .2. Effects of nootropic therapy in age-associated memory impairment
    Anderer, P
    Saletu, B
    Semlitsch, HV
    Pascual-Marqui, RD
    [J]. NEUROPSYCHOBIOLOGY, 1998, 37 (01) : 28 - 35
  • [6] ANDERER P, NEUROSCIENCE
  • [7] [Anonymous], PSYCHODIAGNOSTIK ALK
  • [8] [Anonymous], JPN J NEUROPSYCHOPH
  • [9] Buspirone: Future directions
    Apter, JT
    Allen, LA
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (01) : 86 - 93
  • [10] SEROTONERGIC INTERHEMISPHERIC ASYMMETRY - NEUROCHEMICAL AND PHARMACO-EEG EVIDENCE
    ARATO, M
    FRECSKA, E
    MACCRIMMON, DJ
    GUSCOTT, R
    SAXENA, B
    TEKES, K
    TOTHFALUSI, L
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1991, 15 (06) : 759 - 764